Roche Withdraws Premerger Notification On Pending Acquisition Of Spark

(RTTNews) - Swiss drug major Roche Holding AG (RHHBY) and Spark Therapeutics, Inc. (ONCE) announced Wednesday that Roche has withdrawn its Premerger Notification and Report Form under the Hart-Scott-Rodino Act in connection with Roche's pending acquisition of Spark.

Roche and Spark both filed a Premerger Notification and Report Form under the HSR Act on March 1, 2019 with respect to the pending acquisition. On March 18, Roche withdrew the March 1 filing and refiled a Premerger Notification and Report Form.

Roche has withdrawn the March 18 filing effective on April 2, and intends to refile a Premerger Notification and Report Form under the HSR Act on or about April 10.

Following such refiling, the waiting period applicable to the pending acquisition will expire at 11:59 p.m., New York City time, on or about April 25.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ONCE RHHBY